Table 4.

Clinical Outcomes in Non–LAD-Deferred Patients

	Unadjusted				Adjusted
	iFR Group (n = 343)	FFR Group (n = 327)	Hazard Ratio (95% CI)	p Value	Hazard Ratio (95% CI)	p Value
MACE (cardiovascular death, MI, unplanned revascularization)	18 (5.25)	17 (5.20)	1.22 (0.60–2.44)	0.58	1.18 (0.59–2.38)	0.63
Cardiovascular death	3 (0.87)	0 (0.00)
MACE (all-cause death, MI, unplanned revascularization)	20 (5.83)	21 (6.42)	1.05 (0.56–1.99)	0.88	1.04 (0.55–1.97)	0.9
All-cause death	5 (1.46)	4 (1.22)	1.20 (0.32–4.48)	0.78	1.28 (0.34–4.76)	0.72
MI	5 (1.46)	6 (1.83)	1.20 (0.32–4.45)	0.79	1.09 (0.29–4.08)	0.89
Target vessel MI	2 (0.58)	2 (0.61)	0.96 (0.14–6.83)	0.97	0.87 (0.12–6.15)	0.88
Non-target vessel MI	3 (0.87)	2 (0.61)	1.43 (0.24–8.54)	0.7	1.32 (0.22–7.92)	0.76
Periprocedural MI	0 (0.00)	2 (0.61)
Unplanned revascularization	15 (4.37)	16 (4.89)	1.02 (0.49–2.10)	0.97	0.98 (0.47–2.04)	0.97
TVR	5 (1.46)	10 (3.06)	0.53 (0.18–1.57)	0.25	0.52 (0.17–1.55)	0.24
Non-TVR	10 (2.92)	6 (1.83)	1.90 (0.65–5.55)	0.24	1.80 (0.62–5.29)	0.28

Values are n (%) unless otherwise indicated.